Toomas Marandi

13.4k total citations · 1 hit paper
23 papers, 342 citations indexed

About

Toomas Marandi is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Toomas Marandi has authored 23 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Surgery. Recurrent topics in Toomas Marandi's work include Acute Myocardial Infarction Research (13 papers), Heart Failure Treatment and Management (7 papers) and Cardiac Imaging and Diagnostics (6 papers). Toomas Marandi is often cited by papers focused on Acute Myocardial Infarction Research (13 papers), Heart Failure Treatment and Management (7 papers) and Cardiac Imaging and Diagnostics (6 papers). Toomas Marandi collaborates with scholars based in Estonia, Sweden and Norway. Toomas Marandi's co-authors include Tiia Ainla, Jaan Eha, Marja­‐Liisa Dahl, Aleksei Baburin, Aet Saar, Tomas Jernberg, Jan‐Olof Svensson, Veiko Vasar, Raul‐Allan Kiivet and Thomas Kellerth and has published in prestigious journals such as New England Journal of Medicine, European Heart Journal and Psychopharmacology.

In The Last Decade

Toomas Marandi

23 papers receiving 331 citations

Hit Papers

Beta-Blockers after Myocardial Infarction and Preserved E... 2024 2026 2025 2024 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
    2024 99 citations Troels Yndigegn, Bertil Lindahl et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toomas Marandi Estonia 10 205 65 62 45 36 23 342
C. Dansirikul Australia 8 241 1.2× 17 0.3× 23 0.4× 46 1.0× 19 0.5× 11 436
Ines Potočnjak Croatia 11 133 0.6× 17 0.3× 13 0.2× 60 1.3× 29 0.8× 34 390
Alfred Cecchetti United States 7 110 0.5× 12 0.2× 55 0.9× 33 0.7× 14 0.4× 19 276
Michael Fisher United Kingdom 12 211 1.0× 104 1.6× 20 0.3× 102 2.3× 7 0.2× 23 382
Giuseppe Campolongo Italy 9 152 0.7× 35 0.5× 23 0.4× 83 1.8× 9 0.3× 16 338
Heather Falvey United States 10 214 1.0× 126 1.9× 10 0.2× 40 0.9× 17 0.5× 32 576
Ching‐Ming Yeh United States 13 271 1.3× 19 0.3× 39 0.6× 21 0.5× 27 0.8× 18 466
Jonathan Thigpen United States 8 131 0.6× 7 0.1× 79 1.3× 28 0.6× 10 0.3× 19 295
Jan Stålhammar Sweden 16 184 0.9× 18 0.3× 11 0.2× 92 2.0× 13 0.4× 36 580

Countries citing papers authored by Toomas Marandi

Since Specialization
Citations

This map shows the geographic impact of Toomas Marandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toomas Marandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toomas Marandi more than expected).

Fields of papers citing papers by Toomas Marandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toomas Marandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toomas Marandi. The network helps show where Toomas Marandi may publish in the future.

Co-authorship network of co-authors of Toomas Marandi

This figure shows the co-authorship network connecting the top 25 collaborators of Toomas Marandi. A scholar is included among the top collaborators of Toomas Marandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toomas Marandi. Toomas Marandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yndigegn, Troels, Bertil Lindahl, Joakim Alfredsson, et al.. (2024). Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. New England Journal of Medicine. 390(15). 1372–1381. 99 indexed citations breakdown →
2.
Yndigegn, Troels, Bertil Lindahl, Joakim Alfredsson, et al.. (2022). Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). European Heart Journal - Cardiovascular Pharmacotherapy. 9(2). 192–197. 15 indexed citations
3.
Jortveit, Jarle, Tamás Ferenci, Christian Lewinter, et al.. (2022). Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries. European Heart Journal Open. 2(4). oeac042–oeac042. 15 indexed citations
4.
Talving, Peep, et al.. (2022). Associations between elevated high-sensitive cardiac troponin t and outcomes in patients with acute abdominal pain. European Journal of Trauma and Emergency Surgery. 49(1). 281–288. 1 indexed citations
5.
Reigo, Anu, Margit Nõukas, Liis Leitsalu, et al.. (2022). Do Biobank Recall Studies Matter? Long-Term Follow-Up of Research Participants With Familial Hypercholesterolemia. Frontiers in Genetics. 13. 936131–936131. 2 indexed citations
6.
Edfors, Robert, Tomas Jernberg, Christian Lewinter, et al.. (2021). Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries. European Heart Journal - Quality of Care and Clinical Outcomes. 8(4). 429–436. 8 indexed citations
7.
Ainla, Tiia, Jaan Eha, Toomas Marandi, et al.. (2021). Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries. European Heart Journal - Quality of Care and Clinical Outcomes. 8(3). 307–314. 23 indexed citations
8.
9.
Ainla, Tiia, Péter Andréka, Robert Edfors, et al.. (2020). Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway and Sweden according to national ongoing registries. European Heart Journal. 41(Supplement_2). 2 indexed citations
10.
Brinkman, David J., Silvia Benemei, Ylva Böttiger, et al.. (2019). Appropriate antibiotic prescribing among final-year medical students in Europe. International Journal of Antimicrobial Agents. 54(3). 375–379. 14 indexed citations
11.
Saar, Aet, et al.. (2018). The risk-treatment paradox in non-ST-elevation myocardial infarction patients according to their estimated GRACE risk. International Journal of Cardiology. 272. 26–32. 20 indexed citations
12.
Saar, Aet, et al.. (2015). Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country. BMC Cardiovascular Disorders. 15(1). 136–136. 7 indexed citations
13.
14.
15.
Marandi, Toomas, Aleksei Baburin, & Tiia Ainla. (2010). Use of evidence-based pharmacotherapy after myocardial infarction in Estonia. BMC Public Health. 10(1). 358–358. 9 indexed citations
16.
Ainla, Tiia, et al.. (2010). Better outcomes for acute myocardial infarction patients first admitted to PCI hospitals in Estonia. Acta cardiologica. Supplementum. 65(5). 541–548. 4 indexed citations
17.
Ainla, Tiia, et al.. (2006). Diagnosis and treatment of acute myocardial infarction in tertiary and secondary care hospitals in Estonia. Scandinavian Journal of Social Medicine. 34(3). 327–331. 6 indexed citations
18.
19.
Marandi, Toomas, Marja­‐Liisa Dahl, Lembit Rägo, Raul Allan Kiivet, & Folke Sjöqvist. (1997). Debrisoquine and S -mephenytoin hydroxylation polymorphisms in a Russian population living in Estonia. European Journal of Clinical Pharmacology. 53(3-4). 257–260. 15 indexed citations
20.
Marandi, Toomas, Marja­‐Liisa Dahl, Raul Allan Kiivet, Lembit Rägo, & Folke Sjöqvist. (1996). Debrisoquin and S‐Mephenytoin Hydroxylation Phenotypes and CYP2D6 Genotypes in an Estonian Population. Pharmacology & Toxicology. 78(5). 303–307. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Dansirikul Breakdown of academic impact, for papers by Ines Potočnjak Breakdown of academic impact, for papers by Alfred Cecchetti Breakdown of academic impact, for papers by Michael Fisher Breakdown of academic impact, for papers by Giuseppe Campolongo Breakdown of academic impact, for papers by Heather Falvey Breakdown of academic impact, for papers by Ching‐Ming Yeh Breakdown of academic impact, for papers by Jonathan Thigpen Breakdown of academic impact, for papers by Jan Stålhammar
Rankless by CCL
2026